Skip main navigation
Close Drawer MenuOpen Drawer Menu
Books

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
No Access

Chapter 13.Methadone and Buprenorphine Maintenance Treatment of Opioid-Related Disorders

Edited by:
    https://doi.org/10.1176/appi.books.9781615373970.kb13

    Sections

    Methadone Treatment | Buprenorphine Treatment | Conclusion | References

    Excerpt

    In this chapter we review the use of methadone and buprenorphine for the treatment of opioid-related disorders. Both of these medications are effective and safe and are widely used throughout the world.

    Access content

    To read the fulltext, please use one of the options below to sign in or purchase access.
    • Institutional Login
    • Sign in via OpenAthens
    • Register for access

    • Please login/register if you wish to pair your device and check access availability.

      Not a subscriber?

      Subscribe Now / Learn More

      PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

      Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).